Rampertab Shameze - 04 Feb 2024 Form 4 Insider Report for ASENSUS SURGICAL, INC.

Signature
/s/ Joshua Weingard as attorney-in-fact for Shameze Rampertab
Issuer symbol
N/A
Transactions as of
04 Feb 2024
Net transactions value
-$40,599
Form type
4
Filing time
06 Feb 2024, 19:01:47 UTC
Previous filing
05 Jul 2023
Next filing
23 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASXC Common Stock Options Exercise $0 +280,909 +113% $0.000000 528,772 04 Feb 2024 Direct
transaction ASXC Common Stock Tax liability $40,599 -150,367 -28% $0.2700 378,405 04 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASXC Stock Options Award $0 +396,800 $0.000000 396,800 06 Feb 2024 Common Stock 396,800 $0.2600 Direct F2
transaction ASXC Restricted Stock Units Award $0 +660,600 $0.000000 660,600 06 Feb 2024 Common Stock 660,600 $0.000000 Direct F3, F4
transaction ASXC Restricted Stock Units Award $0 +330,300 $0.000000 330,300 06 Feb 2024 Common Stock 330,300 $0.000000 Direct F5, F6
transaction ASXC Restricted Stock Units Options Exercise $0 -19,704 -100% $0.000000* 0 04 Feb 2024 Common Stock 19,704 $0.000000 Direct F3, F7
transaction ASXC Restricted Stock Units Options Exercise $0 -19,704 -100% $0.000000* 0 04 Feb 2024 Common Stock 19,704 $0.000000 Direct F5, F8
transaction ASXC Restricted Stock Units Options Exercise $0 -62,417 -50% $0.000000 62,417 04 Feb 2024 Common Stock 62,417 $0.000000 Direct F3, F9
transaction ASXC Restricted Stock Units Options Exercise $0 -62,417 -50% $0.000000 62,417 04 Feb 2024 Common Stock 62,417 $0.000000 Direct F5, F10
transaction ASXC Restricted Stock Units Options Exercise $0 -58,334 -33% $0.000000 116,666 04 Feb 2024 Common Stock 58,334 $0.000000 Direct F3, F11
transaction ASXC Restricted Stock Units Options Exercise $0 -58,333 -33% $0.000000 116,667 04 Feb 2024 Common Stock 58,333 $0.000000 Direct F5, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
F2 Vests one-third annually on each of February 6, 2025, 2026 and 2027, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
F3 Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
F4 Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2025, 2026 and 2027, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
F5 Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
F6 PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are met.
F7 Lapse of forfeiture on third one-third of an award of RSUs from a grant made on February 8, 2021.
F8 Lapse of forfeiture restrictions on third one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals.
F9 Lapse of forfeiture restrictions on the second one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
F10 Lapse of forfeiture restrictions on the second one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
F11 Lapse of forfeiture restrictions on one-third of a RSU award granted on February 3, 2023. Forfeiture restrictions will lapse on the remaining RSUs on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and teh Reporting Person's Employment Agreement.
F12 Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan ad the Reporting Person's Employment Agreement.